Inside Washington: Costs and Controls Challenge Manufacturers

February 15, 2002

Jill Wechsler

Jill Wechsler

Jill Wechsler is BioPharm International's Washington Editor, jillwechsler7@gmail.com.

BioPharm International, BioPharm International-02-01-2002, Volume 15, Issue 2

Page Number: 52-56

By Jill Wechsler, pp. 52-56. More curbs on reimbursement for expensive, cutting-edge therapies may shape R&D programs and industry growth

Related Content:

Using a Model and Tools to Standardize the Preparation for a Preapproval Inspection

Sale of Your Product Can Prevent Patenting: How to Avoid the On-Sale Bar

Outsourcing Outlook: Reaping the Benefits of E-Procurement